Pfizer Could Launch Three Significant NMEs in 2004; Will Any Surpass Viagra?

Pfizer's product outlook is brightening in 2004, with the launch of three commercially significant new molecular entity products on the horizon

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet